Pharmaceutical Research Associates, Inc. (PRA)
Also known as: Medical Director & Head of Clinical Unit, PRA International | Pharmaceutical Research Associates | Pharmaceutical Research, Dallas, USA | Pharmaceuticals Research Association (PRA), BV | PHARMA RES SOFTWARE | PHARM RES ASSOC | PRA | PRA Clinic Netherlands | PRA - CRI Lifetree | PRA/CRI Lifetree Research Center | PRA Early Development Clinic | PRA-EDS | PRA Group B.V., a PRA Health Sciences company | PRA Health Sciences | PRA Health Sciences for clinical study conduct. | PRA Health Sciences (PRA) - Early Development Services (EDS) | PRA International - Clinical Pharmacology Center | PRA International Group BV | PRA International, Inc | PRA International, The Netherlands | PRA Research Physician
Highest phase reached
Phase 4
Timeline
1950s
- Jun 25, 1958
trolamine polypeptide oleate condensate— NDA Organization
1970s
- Oct 7, 1977
sulfaphenazole— NDA Secondary Org
1980s
- Jan 1, 1982
Pharmaceutical Research Associates, Inc. (PRA)— Founded
- Mar 4, 1986
acetaminophen— Marketing Organization
2000s
- Jun 6, 2005
Regulatory/Clinical Consultants— Acquired
- May 24, 2006
Sterling Synergy Systems— Acquired
- Jun 19, 2006
Pharma Bio-Research Group B.V., Zuidlaren, The Netherlands— Acquired
2010s
- Mar 4, 2013
ClinStar, LLC— Acquired
- Sep 24, 2013
ReSearch Pharmaceutical Services— Acquired
- Nov 13, 2013
CRI Worldwide— Acquired - Aug 3, 2015
Value Health Solutions— Acquired
- Mar 18, 2016
Nextrials, Inc.— Acquired
- Aug 9, 2017
Parallel 6— Acquired
2020s
- Feb 23, 2021
ICON— Acquired By
Drugs by trial phase (178 distinct, 166 trials)
Phase 4 (2 own, 1 via acquisition)
Phase 3 (32 own, 8 via acquisition)
Phase 2 (40 own, 5 via acquisition)
Phase 1 (83 own, 7 via acquisition)
Indications
Approved for
Studied for
- Acromegaly
- Adenocarcinoma
- Alzheimer Disease
- Amyloidosis
- Anorexia
- Arthritis
- Arthritis, Juvenile
- Arthritis, Psoriatic
- Arthritis, Rheumatoid
- Asthma
- Atrial Fibrillation
- Atrophy
- Bipolar Disorder
- Blood Coagulation Disorders
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Cachexia
- Carcinoma
- Carcinoma, Squamous Cell
- Cholangitis
- Cognition Disorders
- Colitis
- Colitis, Ulcerative
- Communicable Diseases
- Constipation
- Crohn Disease
- Depressive Disorder
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Drug-Related Side Effects and Adverse Reactions
- Eczema
- Encephalitis
- Encephalitis, Japanese
- Epilepsies, Partial
- Epilepsy
- Epilepsy, Reflex
- Fatty Liver
- Graft vs Host Disease
- Hemochromatosis
- Hemostatic Disorders
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Herpesviridae Infections
- Hidradenitis
- Hidradenitis Suppurativa
- Hyperplasia
- Hypokinesia
- Hypotension
- Immunoglobulin Light-chain Amyloidosis
- Infections
- Infertility
- Infertility, Female
- Intraabdominal Infections
- Invasive Fungal Infections
- Iron Overload
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Liver Diseases
- Lupus Erythematosus, Systemic
- Major Depressive Disorder
- Marburg Virus Disease
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
- Muscular Atrophy
- Muscular Atrophy, Spinal
- Mycoses
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Opioid-Related Disorders
- Osteoarthritis
- Pancreatic Neoplasms
- Parkinson Disease
- Prostatic Hyperplasia
- Psoriasis
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Respiratory Insufficiency
- Respiratory Syncytial Virus Infections
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Seasonal
- Schizophrenia
- Sclerosis
- Seizures
- Sepsis
- Sexual Dysfunctions, Psychological
- Sjogren's Syndrome
Marketed drugs (11)
Subsidiaries (9 direct, 10 total across the full acquisition tree)
Recent trials (50)
- NCT05541159CollaboratorPhase 1Mar 20, 2023
- NCT05490030CollaboratorPhase 1Feb 27, 2023
- NCT05408663CollaboratorPhase 1Jul 11, 2022
- NCT05124483CollaboratorPhase 2Dec 1, 2021
- NCT04874948Overall official - principal investigatorPhase 1Sep 21, 2021
- NCT05043766CollaboratorPhase 1Sep 8, 2021
- NCT04857840CollaboratorPhase 3Aug 5, 2021
- NCT04909242Overall official - principal investigatorPhase 1May 6, 2021
- NCT04731298CollaboratorPhase 2Apr 15, 2021
- NCT04828005Overall official - principal investigatorPhase 1Mar 30, 2021
- NCT04457076CollaboratorPhase 3Dec 31, 2020
- NCT04783753CollaboratorPhase 1Nov 5, 2020
- NCT04470388CollaboratorPhase 1Sep 9, 2020
- NCT04559126CollaboratorPhase 1Sep 8, 2020
- NCT04520360CollaboratorPhase 1Aug 27, 2020
Details
- Founded
- Charlottesville, VA, US Jan 1, 1982
- Last known activity
- Mar 20, 2023